- A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses. Guzzo, C.A., Weiss, J.S., Mogavero, H.S., Ellis, C.N., Zaias, N., Lowe, N.J., Kerdel, F.A., Milbauer, J.J., Bernhard, J.D., Whitmore, C. J. Am. Acad. Dermatol. (1991)